Skip to main content
Erschienen in: International Journal of Clinical Pharmacy 5/2023

08.09.2023 | Research Article

Between what is and what could be: a survey of pharmacists’ practices, attitudes, and beliefs in the provision of mental health care

verfasst von: Amy Soubolsky, Katelyn Halpape, Derek Jorgenson, Alfred J. Remillard, Candace Necyk

Erschienen in: International Journal of Clinical Pharmacy | Ausgabe 5/2023

Einloggen, um Zugang zu erhalten

Abstract

Background

Pharmacists can have an essential role in providing care for patients with mental illness. There are gaps in the understanding of the current extent of pharmacists’ involvement in caring for patients with mental illness and their readiness to effectively provide this care.

Aim

To describe the current practices, attitudes, and beliefs of pharmacists in providing care to individuals with mental illness, and to assess factors that may impact these practices.

Method

An electronic questionnaire was emailed to pharmacists in Saskatchewan, Canada. Likert scale questions were utilized, and data were analyzed using descriptive statistics and content analysis for free-text responses.

Results

The response rate was 9.1% (n = 146/1596). Fewer than 20% of respondents reported they were providing the clinical services listed to most or all patients with mental illness, except for providing basic medication education (61%). Almost all agreed it is a pharmacist’s role to provide all the services (61–98% for different services) and many were motivated to provide them (47–91%). The factors most frequently selected as having the greatest impact on service provision were insufficient knowledge (27%, n = 34) and competing priorities (19%, n = 24).

Conclusion

Consistent with international trends, Saskatchewan pharmacists reported low provision of clinical services for individuals with mental illness, despite a readiness to provide these services. There is an opportunity and a need to better utilize pharmacists internationally in the provision of mental health care.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
6.
Zurück zum Zitat Walker ER, McGee RE, Druss BG. Mortality in mental disorders and global disease burden implications a systematic review and meta-analysis. JAMA Psychiatry. 2015;72(4):334–41.PubMedPubMedCentralCrossRef Walker ER, McGee RE, Druss BG. Mortality in mental disorders and global disease burden implications a systematic review and meta-analysis. JAMA Psychiatry. 2015;72(4):334–41.PubMedPubMedCentralCrossRef
8.
Zurück zum Zitat Kohn R, Saxena S, Levav I, et al. The treatment gap in mental health care. Bull World Health Organ. 2004;82(11):858–66.PubMedPubMedCentral Kohn R, Saxena S, Levav I, et al. The treatment gap in mental health care. Bull World Health Organ. 2004;82(11):858–66.PubMedPubMedCentral
11.
Zurück zum Zitat Bell JS, Whitehead P, Aslani P, et al. Drug-related problems in the community setting: pharmacists’ findings and recommendations for people with mental illnesses. Clin Drug Investig. 2006;26(7):415–25.PubMedCrossRef Bell JS, Whitehead P, Aslani P, et al. Drug-related problems in the community setting: pharmacists’ findings and recommendations for people with mental illnesses. Clin Drug Investig. 2006;26(7):415–25.PubMedCrossRef
12.
Zurück zum Zitat García S, Martínez-Cengotitabengoa M, López-Zurbano S, et al. Adherence to antipsychotic medication in bipolar disorder and schizophrenic patients. J Clin Psychopharmacol. 2016;36(4):355–71.PubMedPubMedCentralCrossRef García S, Martínez-Cengotitabengoa M, López-Zurbano S, et al. Adherence to antipsychotic medication in bipolar disorder and schizophrenic patients. J Clin Psychopharmacol. 2016;36(4):355–71.PubMedPubMedCentralCrossRef
13.
Zurück zum Zitat Gallego JA, Bonetti J, Zhang J, et al. Prevalence and correlates of antipsychotic polypharmacy: a systematic review and meta-regression of global and regional trends from the 1970s to 2009. Schizophr Res. 2012;138(1):18–28.PubMedPubMedCentralCrossRef Gallego JA, Bonetti J, Zhang J, et al. Prevalence and correlates of antipsychotic polypharmacy: a systematic review and meta-regression of global and regional trends from the 1970s to 2009. Schizophr Res. 2012;138(1):18–28.PubMedPubMedCentralCrossRef
15.
Zurück zum Zitat Meagher D, Moran M. Sub-optimal prescribing in an adult community mental health service: prevalence and determinants. Psychiatr Bull. 2003;27(7):266–70.CrossRef Meagher D, Moran M. Sub-optimal prescribing in an adult community mental health service: prevalence and determinants. Psychiatr Bull. 2003;27(7):266–70.CrossRef
19.
Zurück zum Zitat Matlala M, Maponya ML, Chigome CK, et al. Overview of mental health: a public health priority. SA Pharm J. 2018;85(6):46–53. Matlala M, Maponya ML, Chigome CK, et al. Overview of mental health: a public health priority. SA Pharm J. 2018;85(6):46–53.
21.
Zurück zum Zitat Liu J, Ma H, He YL, et al. Mental health system in China: history, recent service reform and future challenges. World Psychiatry. 2011;10(3):210–6.PubMedPubMedCentralCrossRef Liu J, Ma H, He YL, et al. Mental health system in China: history, recent service reform and future challenges. World Psychiatry. 2011;10(3):210–6.PubMedPubMedCentralCrossRef
25.
Zurück zum Zitat Cipolle RJ, Strand LM, Morley PC. Chapter 1. Medication management services. In: Cipolle RJ, Strand LM, Morley PC, editors. Pharmaceutical care practice: the patient-centered approach to medication management services, 3rd ed. New York: The McGraw-Hill Companies; 2012. ISBN: 78-0-07-175638-9. Cipolle RJ, Strand LM, Morley PC. Chapter 1. Medication management services. In: Cipolle RJ, Strand LM, Morley PC, editors. Pharmaceutical care practice: the patient-centered approach to medication management services, 3rd ed. New York: The McGraw-Hill Companies; 2012. ISBN: 78-0-07-175638-9.
26.
Zurück zum Zitat Tsuyuki RT, Beahm NP, Okada H, et al. Pharmacists as accessible primary health care providers: review of the evidence. Can Pharm J. 2018;151(1):4–5.CrossRef Tsuyuki RT, Beahm NP, Okada H, et al. Pharmacists as accessible primary health care providers: review of the evidence. Can Pharm J. 2018;151(1):4–5.CrossRef
29.
Zurück zum Zitat Goldstone LW, Dipaula BA, Werremeyer A, et al. The role of board certified psychiatric pharmacists in expanding access to care and improving patient outcomes. Psychiatr Serv. 2021;72(7):794–801.PubMedCrossRef Goldstone LW, Dipaula BA, Werremeyer A, et al. The role of board certified psychiatric pharmacists in expanding access to care and improving patient outcomes. Psychiatr Serv. 2021;72(7):794–801.PubMedCrossRef
31.
Zurück zum Zitat Finley PR, Crismon ML, Rush AJ. Evaluating the impact of pharmacists in mental health: a systematic review. Pharmacotherapy. 2003;23(12):1634–44.PubMedCrossRef Finley PR, Crismon ML, Rush AJ. Evaluating the impact of pharmacists in mental health: a systematic review. Pharmacotherapy. 2003;23(12):1634–44.PubMedCrossRef
34.
Zurück zum Zitat Goldstone LW, DiPaula BA, Caballero J, et al. Improving medication-related outcomes for patients with psychiatric and neurologic disorders: value of psychiatric pharmacists as part of the health care team. Ment Health Clin. 2015;5(1):1–28.CrossRef Goldstone LW, DiPaula BA, Caballero J, et al. Improving medication-related outcomes for patients with psychiatric and neurologic disorders: value of psychiatric pharmacists as part of the health care team. Ment Health Clin. 2015;5(1):1–28.CrossRef
35.
Zurück zum Zitat Kaboli PJ, Hoth AB, McClimon BJ, et al. Clinical pharmacists and inpatient medical care: a systematic review. Arch Intern Med. 2006;166(9):955–64.PubMedCrossRef Kaboli PJ, Hoth AB, McClimon BJ, et al. Clinical pharmacists and inpatient medical care: a systematic review. Arch Intern Med. 2006;166(9):955–64.PubMedCrossRef
37.
Zurück zum Zitat Hattingh HL, Scahill S, Fowler JL, et al. Exploring an increased role for Australian community pharmacy in mental health professional service delivery: evaluation of the literature. J Ment Health. 2016;25(6):550–9.PubMedCrossRef Hattingh HL, Scahill S, Fowler JL, et al. Exploring an increased role for Australian community pharmacy in mental health professional service delivery: evaluation of the literature. J Ment Health. 2016;25(6):550–9.PubMedCrossRef
38.
Zurück zum Zitat Rubio-Valera M, Chen TF, O’Reilly CL, et al. New roles for pharmacists in community mental health care: a narrative review. Int J Environ Res Public Health. 2014;11(10):10967–90.PubMedPubMedCentralCrossRef Rubio-Valera M, Chen TF, O’Reilly CL, et al. New roles for pharmacists in community mental health care: a narrative review. Int J Environ Res Public Health. 2014;11(10):10967–90.PubMedPubMedCentralCrossRef
40.
Zurück zum Zitat Canales PL, Dorson PG, Crismon ML. Outcomes assessment of clinical pharmacy services in a psychiatric inpatient setting. Am J Health Syst Pharm. 2001;58(14):1309–16.PubMedCrossRef Canales PL, Dorson PG, Crismon ML. Outcomes assessment of clinical pharmacy services in a psychiatric inpatient setting. Am J Health Syst Pharm. 2001;58(14):1309–16.PubMedCrossRef
41.
Zurück zum Zitat Finley PR, Rens HR, Pont JT, et al. Impact of a collaborative pharmacy practice model on the treatment of depression in primary care. Am J Health Syst Pharm. 2002;59(16):1518–26.PubMedCrossRef Finley PR, Rens HR, Pont JT, et al. Impact of a collaborative pharmacy practice model on the treatment of depression in primary care. Am J Health Syst Pharm. 2002;59(16):1518–26.PubMedCrossRef
42.
Zurück zum Zitat Marques LA, Galduróz JC, Fernandes MR, et al. Assessment of the effectiveness of pharmacotherapy follow-up in patients treated for depression. J Manag Care Pharm. 2013;19(3):218–27.PubMed Marques LA, Galduróz JC, Fernandes MR, et al. Assessment of the effectiveness of pharmacotherapy follow-up in patients treated for depression. J Manag Care Pharm. 2013;19(3):218–27.PubMed
43.
Zurück zum Zitat Caballero J, Souffrant G, Heffernan E. Development and outcomes of a psychiatric pharmacy clinic for indigent patients. Am J Health Syst Pharm. 2008;65(3):229–33.PubMedCrossRef Caballero J, Souffrant G, Heffernan E. Development and outcomes of a psychiatric pharmacy clinic for indigent patients. Am J Health Syst Pharm. 2008;65(3):229–33.PubMedCrossRef
44.
Zurück zum Zitat Finley PR, Bluml BM, Bunting BA, et al. Clinical and economic outcomes of a pilot project examining pharmacist-focused collaborative care treatment for depression. J Am Pharm Assoc. 2011;51(1):40–9.CrossRef Finley PR, Bluml BM, Bunting BA, et al. Clinical and economic outcomes of a pilot project examining pharmacist-focused collaborative care treatment for depression. J Am Pharm Assoc. 2011;51(1):40–9.CrossRef
45.
Zurück zum Zitat Herbert C, Winkler H. Impact of a clinical pharmacist-managed clinic in primary care mental health integration at a Veterans Affairs health system. Ment Health Clin. 2018;8(3):105–9.PubMedPubMedCentralCrossRef Herbert C, Winkler H. Impact of a clinical pharmacist-managed clinic in primary care mental health integration at a Veterans Affairs health system. Ment Health Clin. 2018;8(3):105–9.PubMedPubMedCentralCrossRef
48.
Zurück zum Zitat Giannetti V, Caley CF, Kamal KM, et al. Community pharmacists and mental illness: a survey of service provision, stigma, attitudes and beliefs. Int J Clin Pharm. 2018;40(5):1096–105.PubMedCrossRef Giannetti V, Caley CF, Kamal KM, et al. Community pharmacists and mental illness: a survey of service provision, stigma, attitudes and beliefs. Int J Clin Pharm. 2018;40(5):1096–105.PubMedCrossRef
49.
Zurück zum Zitat Cates ME, Burton AR, Woolley TW. Attitudes of pharmacists toward mental illness and providing pharmaceutical care to the mentally ill. Ann Pharmacother. 2005;39(9):1450–5.PubMedCrossRef Cates ME, Burton AR, Woolley TW. Attitudes of pharmacists toward mental illness and providing pharmaceutical care to the mentally ill. Ann Pharmacother. 2005;39(9):1450–5.PubMedCrossRef
50.
Zurück zum Zitat Scheerder G, De Coster I, Van Audenhove C. Pharmacists’ role in depression care: A survey of attitudes, current practices, and barriers. Psychiatr Serv. 2008;59(10):1155–60.PubMedCrossRef Scheerder G, De Coster I, Van Audenhove C. Pharmacists’ role in depression care: A survey of attitudes, current practices, and barriers. Psychiatr Serv. 2008;59(10):1155–60.PubMedCrossRef
51.
Zurück zum Zitat Haslam L, Gardner DM, Murphy AL. A retrospective analysis of patient care activities in a community pharmacy mental illness and addictions program. Res Social Adm Pharm. 2020;16(4):522–8.PubMedCrossRef Haslam L, Gardner DM, Murphy AL. A retrospective analysis of patient care activities in a community pharmacy mental illness and addictions program. Res Social Adm Pharm. 2020;16(4):522–8.PubMedCrossRef
53.
Zurück zum Zitat Cipolle RJ, Strand LM, Morley PC. Pharmaceutical care practice: the patient-centered approach to medication management services. 3rd ed. New York: The McGraw-Hill Companies; 2012. ISBN: 78-0-07-175638-9. Cipolle RJ, Strand LM, Morley PC. Pharmaceutical care practice: the patient-centered approach to medication management services. 3rd ed. New York: The McGraw-Hill Companies; 2012. ISBN: 78-0-07-175638-9.
55.
Zurück zum Zitat American Psychiatric Association. Substance-Related and Addictive Disorders. Diagnostic and Statistical Manual of Mental Disorders, 5th ed. American Psychiatric Association; 2013. ISBN: 978-0890425558. American Psychiatric Association. Substance-Related and Addictive Disorders. Diagnostic and Statistical Manual of Mental Disorders, 5th ed. American Psychiatric Association; 2013. ISBN: 978-0890425558.
56.
Zurück zum Zitat Stemler S. An overview of content analysis. Pract Assess Res Eval. 2000;7(1):17. Stemler S. An overview of content analysis. Pract Assess Res Eval. 2000;7(1):17.
57.
Zurück zum Zitat Moser A, Korstjens I. Series: practical guidance to qualitative research. Part 3: sampling, data collection and analysis. Eur J Gen Pract. 2018;24(1):9–18.PubMedCrossRef Moser A, Korstjens I. Series: practical guidance to qualitative research. Part 3: sampling, data collection and analysis. Eur J Gen Pract. 2018;24(1):9–18.PubMedCrossRef
58.
59.
Zurück zum Zitat Isenor JE, Cossette B, Murphy AL, et al. Community pharmacists’ expanding roles in supporting patients before and during COVID-19: An exploratory qualitative study. Int J Clin Pharm. 2023;45(1):64–78.PubMedCrossRef Isenor JE, Cossette B, Murphy AL, et al. Community pharmacists’ expanding roles in supporting patients before and during COVID-19: An exploratory qualitative study. Int J Clin Pharm. 2023;45(1):64–78.PubMedCrossRef
60.
Zurück zum Zitat Goodman CS, Smith TJ, LaMotte JM. A survey of pharmacists’ perceptions of the adequacy of their training for addressing mental health–related medication issues. Ment Health Clin. 2018;7(2):69–73.PubMedPubMedCentralCrossRef Goodman CS, Smith TJ, LaMotte JM. A survey of pharmacists’ perceptions of the adequacy of their training for addressing mental health–related medication issues. Ment Health Clin. 2018;7(2):69–73.PubMedPubMedCentralCrossRef
61.
Zurück zum Zitat Murphy AL, Gardner DM, Jacobs LM. Patient care activities by community pharmacists in a capitation funding model mental health and addictions program. BMC Psychiatry. 2018;18(1):192.PubMedPubMedCentralCrossRef Murphy AL, Gardner DM, Jacobs LM. Patient care activities by community pharmacists in a capitation funding model mental health and addictions program. BMC Psychiatry. 2018;18(1):192.PubMedPubMedCentralCrossRef
62.
Zurück zum Zitat Murphy AL, Martin-Misener R, Kutcher SP, et al. From personal crisis care to convenience shopping: an interpretive description of the experiences of people with mental illness and addictions in community pharmacies. BMC Health Serv Res. 2016;16(1):569.PubMedPubMedCentralCrossRef Murphy AL, Martin-Misener R, Kutcher SP, et al. From personal crisis care to convenience shopping: an interpretive description of the experiences of people with mental illness and addictions in community pharmacies. BMC Health Serv Res. 2016;16(1):569.PubMedPubMedCentralCrossRef
64.
Zurück zum Zitat Bell Lynum KS, Hill AM. Psychiatric services: a platform for MTM. J Pharm Pract. 2015;28(1):13–20.CrossRef Bell Lynum KS, Hill AM. Psychiatric services: a platform for MTM. J Pharm Pract. 2015;28(1):13–20.CrossRef
65.
Zurück zum Zitat Eaves S, Gonzalvo J, Hamm JA, et al. The evolving role of the pharmacist for individuals with serious mental illness. J Am Pharm Assoc. 2020;60(5S):S11–4.CrossRef Eaves S, Gonzalvo J, Hamm JA, et al. The evolving role of the pharmacist for individuals with serious mental illness. J Am Pharm Assoc. 2020;60(5S):S11–4.CrossRef
66.
Zurück zum Zitat Moore T, Groppi J, Ourth H, et al. Increasing access to care using clinical pharmacy specialist providers in outpatient mental health: Successful practice integration within the Department of Veterans Affairs. J Am Pharm Assoc. 2020;60(5S):S107–12.CrossRef Moore T, Groppi J, Ourth H, et al. Increasing access to care using clinical pharmacy specialist providers in outpatient mental health: Successful practice integration within the Department of Veterans Affairs. J Am Pharm Assoc. 2020;60(5S):S107–12.CrossRef
67.
Zurück zum Zitat Gable KN, Stunson MJ. Clinical pharmacist interventions on an assertive community treatment team. Community Ment Health J. 2010;46(4):351–5.PubMedCrossRef Gable KN, Stunson MJ. Clinical pharmacist interventions on an assertive community treatment team. Community Ment Health J. 2010;46(4):351–5.PubMedCrossRef
68.
Zurück zum Zitat McMillan SS, Kelly F, Hattingh HL, et al. The impact of a person-centred community pharmacy mental health medication support service on consumer outcomes. J Ment Health. 2018;27(2):164–73.PubMedCrossRef McMillan SS, Kelly F, Hattingh HL, et al. The impact of a person-centred community pharmacy mental health medication support service on consumer outcomes. J Ment Health. 2018;27(2):164–73.PubMedCrossRef
69.
Zurück zum Zitat Knox K, Hattingh L, Wheeler AJ. Community pharmacy staff motivations and barriers to working with mental health consumers. J Pharm Pract Res. 2016;46(3):245–52.CrossRef Knox K, Hattingh L, Wheeler AJ. Community pharmacy staff motivations and barriers to working with mental health consumers. J Pharm Pract Res. 2016;46(3):245–52.CrossRef
70.
Zurück zum Zitat Phokeo V, Sproule B, Raman-Wilms L. Community pharmacists’ attitudes toward and professional interactions with users of psychiatric medication. Psychiatr Serv. 2004;55(12):1434–6.PubMedCrossRef Phokeo V, Sproule B, Raman-Wilms L. Community pharmacists’ attitudes toward and professional interactions with users of psychiatric medication. Psychiatr Serv. 2004;55(12):1434–6.PubMedCrossRef
71.
Zurück zum Zitat Rickles NM, Dube GL, Mccarter A, et al. Relationship between attitudes toward mental illness and provision of pharmacy services. J Am Pharm Assoc. 2010;50(6):704–13.CrossRef Rickles NM, Dube GL, Mccarter A, et al. Relationship between attitudes toward mental illness and provision of pharmacy services. J Am Pharm Assoc. 2010;50(6):704–13.CrossRef
72.
Zurück zum Zitat Silvia RJ, Lee KC, Bostwick JR, et al. Assessment of the current practice of psychiatric pharmacists in the United States. Ment Health Clin. 2020;10(6):346–53.PubMedPubMedCentralCrossRef Silvia RJ, Lee KC, Bostwick JR, et al. Assessment of the current practice of psychiatric pharmacists in the United States. Ment Health Clin. 2020;10(6):346–53.PubMedPubMedCentralCrossRef
Metadaten
Titel
Between what is and what could be: a survey of pharmacists’ practices, attitudes, and beliefs in the provision of mental health care
verfasst von
Amy Soubolsky
Katelyn Halpape
Derek Jorgenson
Alfred J. Remillard
Candace Necyk
Publikationsdatum
08.09.2023
Verlag
Springer International Publishing
Erschienen in
International Journal of Clinical Pharmacy / Ausgabe 5/2023
Print ISSN: 2210-7703
Elektronische ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-023-01633-6

Weitere Artikel der Ausgabe 5/2023

International Journal of Clinical Pharmacy 5/2023 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhöhte Mortalität bei postpartalem Brustkrebs

07.05.2024 Mammakarzinom Nachrichten

Auch für Trägerinnen von BRCA-Varianten gilt: Erkranken sie fünf bis zehn Jahre nach der letzten Schwangerschaft an Brustkrebs, ist das Sterberisiko besonders hoch.

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

07.05.2024 Harnblasenkarzinom Nachrichten

Eine hypertherme intravesikale Chemotherapie mit Mitomycin kann für Patienten mit hochriskantem nicht muskelinvasivem Blasenkrebs eine Alternative zur radikalen Zystektomie darstellen. Kölner Urologen berichten über ihre Erfahrungen.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Medizinstudium Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Vorhofflimmern bei Jüngeren gefährlicher als gedacht

06.05.2024 Vorhofflimmern Nachrichten

Immer mehr jüngere Menschen leiden unter Vorhofflimmern. Betroffene unter 65 Jahren haben viele Risikofaktoren und ein signifikant erhöhtes Sterberisiko verglichen mit Gleichaltrigen ohne die Erkrankung.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.